These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17299724)

  • 1. Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy.
    Fiore S; Ferrazzi E; Newell ML; Trabattoni D; Clerici M
    J Infect Dis; 2007 Mar; 195(6):914-6; author reply 916-7. PubMed ID: 17299724
    [No Abstract]   [Full Text] [Related]  

  • 2. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
    Cotter AM; Garcia AG; Duthely ML; Luke B; O'Sullivan MJ
    J Infect Dis; 2006 May; 193(9):1195-201. PubMed ID: 16586354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.
    Ravizza M; Martinelli P; Bucceri A; Fiore S; Alberico S; Tamburrini E; Tibaldi C; Guaraldi G; Anzidei G; Maccabruni A; Crisalli MP; Floridia M;
    J Infect Dis; 2007 Mar; 195(6):913-4; author reply 916-7. PubMed ID: 17299723
    [No Abstract]   [Full Text] [Related]  

  • 4. Protease inhibitor use during pregnancy: is there an obstetrical risk?
    Tuomala RE; Yawetz S
    J Infect Dis; 2006 May; 193(9):1191-4. PubMed ID: 16586353
    [No Abstract]   [Full Text] [Related]  

  • 5. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitor treatment of HIV-1-infected women may protect against extreme prematurity and very low birth weight.
    Beckerman KP
    J Infect Dis; 2007 Oct; 196(8):1270-1; author reply 1271. PubMed ID: 17955447
    [No Abstract]   [Full Text] [Related]  

  • 7. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.
    Grosch-Woerner I; Puch K; Maier RF; Niehues T; Notheis G; Patel D; Casteleyn S; Feiterna-Sperling C; Groeger S; Zaknun D;
    HIV Med; 2008 Jan; 9(1):6-13. PubMed ID: 18199167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
    Kourtis AP; Schmid CH; Jamieson DJ; Lau J
    AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes.
    Rebordosa C; Kogevinas M; Bech BH; Sørensen HT; Olsen J
    Int J Epidemiol; 2009 Jun; 38(3):706-14. PubMed ID: 19332503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: a case-control study.
    Silveira MF; Ghanem KG; Erbelding EJ; Burke AE; Johnson HL; Singh RH; Zenilman JM
    Int J STD AIDS; 2009 Jul; 20(7):465-9. PubMed ID: 19541887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm delivery risk in relation to maternal HIV infection, history of malaria and other infections among urban Zimbabwean women.
    Noble A; Ning Y; Woelk GB; Mahomed K; Williams MA
    Cent Afr J Med; 2005; 51(5-6):53-8. PubMed ID: 17432432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
    Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
    Onah HE; Ibeziako N; Nkwo PO; Obi SN; Nwankwo TO
    J Obstet Gynaecol; 2008 Apr; 28(3):276-9. PubMed ID: 18569467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on antiretroviral therapy.
    Riordan A; Bugembe T
    Arch Dis Child; 2009 Jan; 94(1):70-4. PubMed ID: 18838416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.
    Lopez-Cortes LF; Ruiz-Valderas R; Rivero A; Camacho A; Marquez-Solero M; Santos J; García-Lazaro M; Viciana P; Rodriguez-Baños J; Ocampo A
    Ther Drug Monit; 2007 Apr; 29(2):171-6. PubMed ID: 17417070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001.
    Harris NS; Fowler MG; Sansom SL; Ruffo N; Lampe MA
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S33-41. PubMed ID: 17825649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing risk profiles of infants who are delivered at late preterm gestations: does it matter?
    Ananth CV; Gyamfi C; Jain L
    Am J Obstet Gynecol; 2008 Oct; 199(4):329-31. PubMed ID: 18928971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.